91 related articles for article (PubMed ID: 19191893)
1. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.
Zagari RM; Bianchi-Porro G; Fiocca R; Gasbarrini G; Roda E; Bazzoli F
Gut; 2007 Apr; 56(4):475-9. PubMed ID: 17028126
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Kabakambira JD; Hategeka C; Page C; Ntirenganya C; Dusabejambo V; Ndoli J; Ngabonziza F; Hale D; Bayingana C; Walker T
BMC Gastroenterol; 2018 Aug; 18(1):134. PubMed ID: 30165823
[TBL] [Abstract][Full Text] [Related]
3. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
Graham DY; Lee YC; Wu MS
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):177-86.e3; Discussion e12-3. PubMed ID: 23751282
[TBL] [Abstract][Full Text] [Related]
4. Seven-day genotypic resistance-guided triple
Papastergiou V; Mathou N; Licousi S; Evgenidi A; Paraskeva KD; Giannakopoulos A; Stavrou PZ; Platsouka E; Karagiannis JA
Ann Gastroenterol; 2018; 31(2):198-204. PubMed ID: 29507466
[TBL] [Abstract][Full Text] [Related]
5. Antibiomania: A Case Report of a Manic Episode Potentially Induced by the Interaction of Clarithromycin and Amoxicillin during H. Pylori Eradication Therapy.
Carrasco JP; Aguilar EJ
Actas Esp Psiquiatr; 2024 Feb; 52(1):57-59. PubMed ID: 38454894
[TBL] [Abstract][Full Text] [Related]
6. Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists.
Thornhill MH; Dayer MJ; Durkin MJ; Lockhart PB; Baddour LM
J Dent Res; 2019 Sep; 98(10):1081-1087. PubMed ID: 31314998
[TBL] [Abstract][Full Text] [Related]
7. Response to: Comment on "First-Line
Sue S; Suzuki N; Shibata W; Sasaki T; Yamada H; Kaneko H; Tamura T; Ishii T; Kondo M; Maeda S
Gastroenterol Res Pract; 2018; 2018():8046838. PubMed ID: 29767036
[No Abstract] [Full Text] [Related]
8. Primary antibiotic resistance of Helicobacter pylori isolates is twofold more frequent in HIV-positive than HIV-negative individuals: A descriptive observational study.
Nkuize M; Vanderpas J; Buset M; Gomez-Galdon M; Delforge M; Miendje-Deyi VY; Muls V; De Wit S
Microbiologyopen; 2021 Jun; 10(3):e1184. PubMed ID: 34180600
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Helicobacter pylori Eradication on Gastric Wall Thickness in Patients Undergoing Laparoscopic Sleeve Gastrectomy.
Ergin A; Çiyiltepe H; Karip AB; Fersahoğlu MM; Bulut NE; Çakmak A; Topaloğlu B; Bilgili AC; Somay A; Taşdelen İ; Akyüz Ü; Memişoğlu K
Obes Surg; 2021 Sep; 31(9):4024-4032. PubMed ID: 34075550
[TBL] [Abstract][Full Text] [Related]
10. Secondary Antibiotic Resistance, Correlation between Genotypic and Phenotypic Methods and Treatment in
Mascellino MT; Oliva A; Miele MC; De Angelis M; Bruno G; Severi C
Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32872117
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin Versus Metronidazole in First-Line
Murata M; Sugimoto M; Mizuno H; Kanno T; Satoh K
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32079208
[TBL] [Abstract][Full Text] [Related]
12. An Economic Modeling Study of
Gweon TG; Kim JS; Kim BW
Gut Liver; 2018 Nov; 12(6):648-654. PubMed ID: 30037167
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical Equivalence of Clarithromycin Oral Dosage Forms Marketed in Nairobi County, Kenya.
Manani RO; Abuga KO; Chepkwony HK
Sci Pharm; 2017 Apr; 85(2):. PubMed ID: 28445444
[TBL] [Abstract][Full Text] [Related]
14. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
15. Optimizing clarithromycin-containing therapy for Helicobacter pylori in the era of antibiotic resistance.
Molina-Infante J; Gisbert JP
World J Gastroenterol; 2014 Aug; 20(30):10338-47. PubMed ID: 25132750
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Eradication Rate between 1- and 2-Week Bismuth-Containing Quadruple Rescue Therapies for Helicobacter pylori Eradication.
Yoon JH; Baik GH; Kim YS; Suk KT; Shin WG; Kim KH; Kim KO; Park CH; Baik IH; Jang HJ; Kim JB; Kae SH; Kim DJ; Kim HY
Gut Liver; 2012 Oct; 6(4):434-9. PubMed ID: 23170146
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Filipec Kanizaj T; Katicic M; Skurla B; Ticak M; Plecko V; Kalenic S
Helicobacter; 2009 Feb; 14(1):29-35. PubMed ID: 19191893
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
19. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
